With β-actin as the reference, the western blot results indicated that the protein expression of Akt1 in the OV-H1 hybrid cells was significantly weaker than that in the hESCs and OVCAR-3 ovarian cancer cells. This evidence concerns the gene ACTB and ovarian carcinoma.